Moderna jumps to an all-time high as Delta variant fear deepens

(Bloomberg) — Moderna climbed to a record high amid growing concern about a more contagious variant of Covid-19 in nations including India, which cleared the import of its vaccine.
The shares rose 5.2 percent to close at $234.46 on Tuesday after Moderna…

Click here to view the original article.